CBU
EDIT icon

CIBC Bancorp USA’s Editas Medicine EDIT Stock Holding History

CIBC Bancorp USA’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,255
Closed -$30.3K – 1964
2026
Q1 		$30.3K Buy
+12,255
New +$25.9K ﹤0.01% 1729

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

CIBC Bancorp USA's EDIT Position: Q2 2026 in Review

CIBC Bancorp USA sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 12,255 shares — an estimated $30.3K sold.

CIBC Bancorp USA first reported a position in EDIT in Q1 2026 and held it in 1 quarter. The position peaked at $30.3K in Q1 2026. 199 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • CIBC Bancorp USA reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • CIBC Bancorp USA sold 12,255 Editas Medicine shares in Q2 2026, an estimated $30.3K.
  • CIBC Bancorp USA first reported a position in Editas Medicine in Q1 2026 and held it in 1 quarter.
  • CIBC Bancorp USA's Editas Medicine position peaked at $30.3K in Q1 2026.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.